2020
DOI: 10.12659/ajcr.921517
|View full text |Cite
|
Sign up to set email alerts
|

Disseminated Disease by Mycobacterium abscessus and Mycobacterium celatum in an Immunocompromised Host

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 16 publications
(15 reference statements)
0
3
0
Order By: Relevance
“…Studies on M. abscessus osteomyelitis are even rarer. This pathogen is characterized as life-threatening in the geriatric community and among individuals with AIDS [ 3 , 12 ]. M. abscessus can also infect immunocompetent individuals.…”
Section: Discussionmentioning
confidence: 99%
“…Studies on M. abscessus osteomyelitis are even rarer. This pathogen is characterized as life-threatening in the geriatric community and among individuals with AIDS [ 3 , 12 ]. M. abscessus can also infect immunocompetent individuals.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, non-tuberculous mycobacteria (NTM) diseases significantly affect patients with HIV, particularly those with advanced immunodeficiency, due to their severe symptoms and complex treatment requirements (6,7). Despite advancements being made in antiretroviral therapy, NTM diseases remain a major cause of morbidity (8).…”
Section: Introductionmentioning
confidence: 99%
“…Mycobacterium abscessus (MAB) is the rapidly growing nontuberculous mycobacteria that ubiquitously exist in the environment and has been isolated from drinking water, household showerheads, hospital wastewater, and plumbing in large quantities [1]. MAB is an opportunistic pathogen of clinical importance because it can infect and colonize the bronchial airways of patients with cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), or bronchiectasis [2] as well as cause disseminated infections in immunocompromised and postsurgical patients [3,4]. Incidents of MAB pulmonary infections have been increasing in recent years [5], causing fatality in 15% of patients [6,7].…”
Section: Introductionmentioning
confidence: 99%